What is NDC 70069-893?

70069-893 is the product NDC for sugammadex, Sugammadex sodium 100 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for sugammadex?

35 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

sugammadex NDC 70069-893 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-893Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0893Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-893-10	7006908931070069089310	10 VIAL, SINGLE-DOSE in 1 CARTON (70069-893-10) / 5 mL in 1 VIAL, SINGLE-DOSE (70069-893-01)Marketed from Jul 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sugammadex
Generic name (nonproprietary): sugammadex
Active ingredients: Sugammadex sodium — 100 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Somerset Therapeutics, LLCNDC labeler code 70069
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215260
Marketing start: Jul 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: gamma-Cyclodextrins (Chemical structure)
Identifiers: Product ID 70069-893_6a17af4d-54a4-4366-bb3c-268afd742d0fSPL ID 6a17af4d-54a4-4366-bb3c-268afd742d0fSPL set ID 70c00636-d4ba-4939-802c-9d5a92435c93RxCUI 1726992, 1727000UNII ERJ6X2MXV7UPC 0370069893012, 0370069892015

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069089310 followed by a unit qualifier and the quantity

Package 70069-0893-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 3, 2026.

Indications (excerpt from the label)

Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC's BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC's marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-893

What is NDC 70069-893?: 70069-893 is the product NDC for sugammadex, Sugammadex sodium 100 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: sugammadex.
What is the active ingredient?: Sugammadex sodium.
Who is the labeler?: Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for sugammadex?: 35 other product NDCs are listed under this name. See all sugammadex NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other sugammadex NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-726	16729-0726-03
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-727	16729-0727-03
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-268	72266-0268-10
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-269	72266-0269-10
Sugammadex	Sugammadex sodium 200 mg/2mL	InjectionIntravenous	B. Braun Medical Inc.	0264-8200	00264-8200-10
Sugammadex	Sugammadex sodium 100 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6270	00641-6270-10
Sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3468	00781-3468-95
Sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3469	00781-3469-95
Sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Dr. Reddy's Laboratories Inc.	43598-924	43598-0924-26
Sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Dr. Reddy's Laboratories Inc.	43598-925	43598-0925-37

All 36 sugammadex NDCs

Other NDCs under ANDA 215260

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215260
Product	Strength	Form · route	Labeler	Product NDC
sugammadexsugammadex sodium	Sugammadex sodium 100 mg/mL	Injection, SolutionIntravenous	Solupharm Pharmazeutische Erzeugnisse GmbH	55579-892
sugammadex	Sugammadex sodium 100 mg/mL	Injection, SolutionIntravenous	Solupharm Pharmazeutische Erzeugnisse GmbH	55579-893
sugammadex	Sugammadex sodium 100 mg/mL	Injection, SolutionIntravenous	Somerset Therapeutics, LLC	70069-892
sugammadex	Sugammadex sodium 100 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7382